pirinixic acid has been researched along with Angiogenesis, Pathologic in 3 studies
pirinixic acid: structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, L | 1 |
| Wang, W | 1 |
| Dai, M | 1 |
| Li, H | 1 |
| Chen, C | 1 |
| Wang, D | 1 |
| Skrypnyk, N | 1 |
| Chen, X | 1 |
| Hu, W | 1 |
| Su, Y | 1 |
| Mont, S | 1 |
| Yang, S | 2 |
| Gangadhariah, M | 1 |
| Wei, S | 2 |
| Falck, JR | 2 |
| Jat, JL | 1 |
| Zent, R | 1 |
| Capdevila, JH | 2 |
| Pozzi, A | 2 |
| Ibanez, MR | 1 |
| Gatica, AE | 1 |
| Mei, S | 1 |
3 other studies available for pirinixic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
PPARĪ± ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Topics: Animals; Antineoplastic Agents; Benzoates; Bezafibrate; Cell Line, Tumor; Cell Movement; Cell Prolif | 2019 |
PPARĪ± activation can help prevent and treat non-small cell lung cancer.
Topics: Animals; Arachidonic Acids; Bezafibrate; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Prol | 2014 |
Peroxisomal proliferator-activated receptor-alpha-dependent inhibition of endothelial cell proliferation and tumorigenesis.
Topics: Animals; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Cytochrome P-450 Enzy | 2007 |